In silico approach for identifying natural lead molecules against SARS-COV-2

SS Gupta, A Kumar, R Shankar, U Sharma - Journal of molecular graphics …, 2021 - Elsevier
lead molecules, which have potential to act as therapeutic candidate against SARS-CoV-2. …
for screening of natural molecule databases toward finding lead molecule against COVID-19. …

Structure-based virtual screening to discover potential lead molecules for the SARS-CoV-2 main protease

A Gahlawat, N Kumar, R Kumar… - Journal of chemical …, 2020 - ACS Publications
… Further, molecular dynamics studies of selected screened compounds confirmed their perfect
… into the SARS-CoV-2 M pro active site and also offers direction for further lead optimization …

[HTML][HTML] Natural products as potential leads against coronaviruses: could they be encouraging structural models against SARS-CoV-2?

IE Orhan, FS Senol Deniz - Natural products and bioprospecting, 2020 - Springer
… In this sense, medicinal plants and the pure natural molecules isolated from … SARS-CoV
and other types of coronaviruses. In the present review, plant extracts and natural molecules

SARS-CoV-2 and cardiovascular complications: From molecular mechanisms to pharmaceutical management

L Wu, AM O'Kane, H Peng, Y Bi, D Motriuk-Smith… - Biochemical …, 2020 - Elsevier
coronavirus disease 2019 (COVID-19), elicited by severe acute respiratory syndrome coronavirus
2 (SARS-CoV… severe pulmonary damage, SARS-CoV-2 infection also leads to a series …

Unravelling lead antiviral phytochemicals for the inhibition of SARS-CoV-2 Mpro enzyme through in silico approach

AB Gurung, MA Ali, J Lee, MA Farah, KM Al-Anazi - Life sciences, 2020 - Elsevier
… the SARS-CoV-2 M pro enzyme with small molecules can … the identification of promising lead
molecules for SARS-CoV-2 M pro … -like molecules to SARS-CoV-2 M pro , SARS-CoV M pro …

[HTML][HTML] Some natural compounds and their analogues having potent anti-SARS-CoV-2 and anti-proteases activities as lead molecules in drug discovery for COVID …

B Dinda, M Dinda, S Dinda, M Chakraborty - European Journal of …, 2022 - Elsevier
SARS-CoV-2 virus life cycle in infected human host cells identified the physical interactions
of virus and human proteins and these interactions leadmolecular details of how SARS-CoV-…

Interaction of small molecules with the SARS-CoV-2 main protease in silico and in vitro validation of potential lead compounds using an enzyme-linked …

E Pitsillou, J Liang, C Karagiannis, K Ververis… - … biology and chemistry, 2020 - Elsevier
… is the SARS-CoV-2 main protease (M pro ), and our aim was to identify lead compounds …
We performed an initial molecular docking screen of 300 small molecules, which included …

[HTML][HTML] On the molecular determinants of the SARS-CoV-2 attack

D Kanduc, Y Shoenfeld - Clinical Immunology (Orlando, Fla.), 2020 - ncbi.nlm.nih.gov
SARS-CoV-2 attacks the respiratory system and reports on a vast peptide sharing between
SARS-CoV-… immune responses following SARS-CoV-2 infection might lead to crossreactions …

Structural insights on the interaction potential of natural leads against major protein targets of SARS-CoV-2: molecular modelling, docking and dynamic simulation …

S Skariyachan, D Gopal, AG Muddebihalkar… - Computers in biology …, 2021 - Elsevier
lead molecules provide significant insights. The present study aimed to predict the interaction
… of natural lead molecules against prospective protein targets of SARS-CoV-2 by molecular

Antitarget, anti-SARS-CoV-2 leads, drugs, and the drug discovery–genetics alliance perspective

C Pozzi, A Vanet, V Francesconi… - Journal of Medicinal …, 2023 - ACS Publications
… , and S proteins at the molecular level, in an attempt to help understand how these variants
may affect the structural and functional behaviors of SARS-CoV-2 proteins and how they may …